Photo from Naveen Pemmaraju/X
Aug 18, 2024, 09:04
Naveen Pemmaraju: Excited to Co-Chair MPN Workshop The Carolinas 2024
Naveen Pemmaraju posted on X:
“Super excited to Co-Chair this MPN event of the year with Ruben A. Mesa!!!
Please join us for top-notch speakers, panels, discussion and debates!!”
Source: Naveen Pemmaraju/X
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.
His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 3, 2025, 20:48
Sep 3, 2025, 20:35
Sep 3, 2025, 20:10
Sep 3, 2025, 19:42
Sep 3, 2025, 18:59
Sep 3, 2025, 18:01
Sep 3, 2025, 17:26
Sep 3, 2025, 16:34